Infectious Diseases Related Content

Data from the Centers for Disease Control and Prevention (CDC) shows that unvaccinated teenagers are nine times likelier to be hospitalised with Omicron.

The human immune system is an intricate web designed to stop invading pathogens - but with over 200 virus species capable of infecting humans, some have a way to break through.

Research demonstrates the ability to prevent COVID-19 from entering human cells through cannabinoid acids binding to a SARS-CoV-2 protein, blocking infection from the virus.

Gerald Misinzo and Mark Rweyemamu tell us about the decade of work done by the SACIDS Foundation for One Health to protect Sub-Saharan Africa

Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.

Peter Bretscher, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, explores important immunological questions

Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™

Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.

Ann Matthysse, Department of Biology, University of North Carolina, explores what exactly a virus is, with a specific focus on RNA viruses and SARS-CoV-2.

According to the latest data, UK COVID infections are at their highest since May, 2020 - with levels especially high in school-aged children.

Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.

Fluvoxamine, a cheap repurposed drug, can cut COVID-19 hospitalisations by up to 30%, according to a new study.

Gill Nye, Executive Head of HR at Cantium Business Solutions, explores the effect long covid will have on the workplace, with a particular focus on occupational health provision.

Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.

According to a new study, a third of leukaemia patients fail to generate an antibody response following two COVID-19 vaccine doses.

According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.

Captain Casey Barton Behravesh of the U.S. Public Health Service, and Director of the CDC One Health Office highlights the CDC’s efforts to nationally and internationally prevent zoonotic diseases.

With a changing climate, animal, insect, and plant species will either adapt or die under new environmental and climate conditions - this brings new challenges in the study of vector-borne infectious diseases.

Andrew Metcalfe, Director of Intelligent Infection Control Services Limited, LumiBio, explores the lessons learned in infection prevention and control.

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.